REFERENCES
- Acharya A., Sanyal S. K., Moulik S. P. Formation and characterization of an useful biological microemulsion system using mixed oil (ricebran oil and isopropyl myristate), polyoxyethylene(2) oleyl (Brij–92), isopropyl alcohol and water. J. Disp. Sci. Technol. 2001a; 22: 551–561, [CSA]
- Acharya A., Sanyal S. K., Moulik S. P. Formation and characterization of a pharmaceutically useful microemulsion derived from isopropyl myristate, polyoxyethylene (4) lauryl ether (Brij-30), isopropyl alcohlo and water. Current Sci. 2001b; 81: 362–370, [CSA]
- Attwood D. Microemulsion. Colloidal Drug Delivery Systems, J. Kreuter. Marcel Dekker, New York 1994
- Bergmeyer H. U., Gawehn K. Methods of Enzymatic Analysis. Academic Press, New York 1974
- Baroli B., Lopez-Quintela M. A., Delgado-Charro M. B., Fadda A. M., Blanc Mendez J. Microemulsions for topical delivery of 8-methoxsalen. J. Control Release 2000; 69: 209–218, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Chakrabarty S., Roy M., Hazra B., Bhattacharya R. K. Induction of apoptosis in human cancer cell lines by diospyrin, a plant-derived bisnaphthoquinonoid, and its synthetic derivatives'. Cancer Lett. 2002; 188: 85–93, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Constantinides P. P. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm. Res 1995; 12: 1561–1572, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cortesi R., Esposito E., Maietti A., Menegatti E., Nastruzzi C. Formulation study of the antitumor drug camptothecin: liposomes, micellar solution and microemulsion. Int. J. Pharm 1997; 159: 95–103, [CSA], [CROSSREF]
- Cortesi R., Nastruzzi C. Liposomes, micelles, and microemulsions as new delivery systems for cytotoxic alkaloids. Pharmaceut. Sci. Technol. Today 1999; 2: 288–298, [CSA], [CROSSREF]
- Corswant Von C., Thorem P., Engstrom S. Triglyceride base microemulsion for intravaneous administration of sparingly soluble substance. J. Pharm. Sci. 1998; 87: 200–208, [CSA], [CROSSREF]
- FAO. Evaluation of food additives and contaminants. 1982, Technical Report Series No.20.FAO/WHO Expert Committee on Food Additives
- FAO/WHO. Toxicological evaluation of general principles and of specifications. 1974; 539, 17th Report of the joint FAO/WHO Expert Committee on Food additives. Technical Report Series World Health Organization.No
- Gregoriadis G. Liposome. Technology, 2nd ed. CRC, Boca Raton, FL 1993; vol 1
- Gupta S., Mukhopadhya L., Moulik S. P. Activity of alkaline phosphatase in water-in-oil microemulsion containing vegetable oil. Ind. J. Biochem. Biophys. 1995; 32: 261–265, [CSA]
- Hazra B., Golenser J., Nechemiya O., et al. Inhibitory activity of diospyrin derivatives on Leishmania major parasites in vitro. Ind. J. Pharmacol. 2002; 34: 422–427, [CSA]
- Hazra B., Sur P., Roy D. K., et al. Biological activity of diospyrin owards Ehrlich carcinoma in Swiss A mice. Planta Med. 1984; 51: 295–297, [CSA]
- IARC Monographs. LyonFrance 1985; 75–78
- Jadhav B. K., Khandelwal K. R., Ketkar A. R., Pisal S. S. Formulation and evaluation of mucoadhesive tablets containing eugenol for the treatment of periodontal diseases. Drug Dev. Ind. Pharm. 2004; 30: 195–203, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kantaria S., Rees G. D., Lawrence M. J. Geletin based organogels: rheology and application in ionophoretic transdermal drug delivery. J. Control Rel. 1999; 60: 355–365, [CSA], [CROSSREF]
- Kreuter J. Nanoparticles. Colloidal Drug Delivery Systems, J. Kreuter. Marcel Dekker, New York 1994
- Lall N., Hazra B., Das Sarma M., Meyer J. J. M. In vitro activity of derivatives of diospyrin against drug—resistant and drug—sensitive strains of Mycobacterium tuberculosis. J. Antimicrob. Chemother. 2003; 51: 435–438, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lawrence M. J. Microemulsions as drug delivery vehicles. Curr. Opin. Coll. Interf. Sci. 1996; 1: 826–832, [CSA]
- Malcomson C., Lawrence M. J. A comparison of the incorporation of the model steroids into non-ionic micellar and microemulsion systems. J. Pharm. Pharmacol. 1993; 45: 141–143, [CSA]
- Malcomson C., Lawrence M. J. Three component non-ionic oil-in-water microemulsions using polyethylene ether surfactants. Coll Surf B: Biointerf. 1995; 4: 97–109, [CSA], [CROSSREF]
- Moreno M., Frutos Ballesteros M., et al. Release of nortriptyline hydrochloride from oil-in-water microemulsion. Chem. Pharm. Bull. 2000; 48: 1623–1627, [PUBMED], [INFOTRIEVE], [CSA]
- Moreno M. A., Frutos P., Ballesteros M. P. Lyophilized lecithin–based oil-in-water microemulsions as a new and low toxic delivery system for amphotericin B. Pharm. Res. 2001; 18: 344–351, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Moulik S. P., Dey G. C., Bhowmik B. B., Panda A. K. Physicochemical studies in microemulsion VI: dynamics and thermodynamics of percolation of water/AOT/n-heptane in presence of sodium cholate and salicylate. J. Phys. Chem. B. 1999; 103: 7122–7129, [CSA], [CROSSREF]
- Oh K. H., Baran J. R., Wade W. H., Weerrasooriy A. V. Temperature insensitive microemulsion phase behavior with nonionic surfactants. J. Disp. Sci. Technol. 1995; 16: 165–188, [CSA]
- Park K. M., Kim C. K. Preparation and evaluation of flurbiprofen loaded microemulsion for parenteral delivery. Int. J. Pharm 1999; 181: 173–179, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Paul B. K., Moulik S. P. Microemulsions: an overview. J. Disp. Sci. 1997; 18: 301–318, [CSA]
- Ray S., Hazra B., Mitra B., et al. Diospyrin, a bisnaphthoquinone: a novel inhibitor of type I DNA topoisomerase of Leishmania donovani. Mol. Pharmacol. 1998; 54: 994–999, [PUBMED], [INFOTRIEVE], [CSA]
- Sarciaux M. J., Alan L., Sado P. A. Using microemulsion for drug delivery of therapeutic peptides. Int. J. Pharm. 1995; 12: 127–136, [CSA], [CROSSREF]
- Selvi R. T., Niranjali S. Inhibition by eugenol of diethylnitrosamine-induced microsomal degranulation. Fitoterapia 1998; 69: 115–117, [CSA]
- Sinha J., Ray B., Medda S., et al. Bacosasaponin C: critical evaluation of antileishmanial properties of various delivery modes. Drug Del. 2002; 9: 55–62, [CSA], [CROSSREF]
- Swenson E. C., Curatolo W. J. Intestinal permeability enhancement for proteins, peptides and other polar drugs:mechanism and potential toxicity. Adv. Drug Del. Rev. 1992; 8: 39–42, [CSA], [CROSSREF]
- Tenjarala S. Microemulsion: an overview and pharmaceutical application. Crit. Rev. Therap. Drug Carrier Sys. 1999; 16: 461–521, [CSA]
- Trotta M. Influence of phase transformation on indomethicin release from microemulsion. J. Control Rel. 1999; 60: 399–405, [CSA], [CROSSREF]
- Trotta M., Gallarate M., Pattarino F., Carlotti M. E. Investigation of phase behavior of systems containing lecithin and 2-acyl lysolecithin derivatives. Int. J. Pharm. 1999; 190: 83–89, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Trotta M., Gasco M R., Pattarini F. Diffusion of steroid hormones from o/w microemulsions:influence of the cosurfactant. Acta Pharm. Technol. 1990; 36: 226–234, [CSA]
- Trotta M., Ugazio E., Gasco M. R. Psedoternary phase diagram of lecithin- based microemulsions: influence of monoalkylphosphates. J. Pharm. Pharmacol. 1995; 47: 451–454, [PUBMED], [INFOTRIEVE], [CSA]
- Uchegbu I. F., Florence A. T. Non-ionic surfactant vesicles (niosomes): physical and pharmaceutical chemistry. Adv. Coll. Interf. Sci. 1995; 58: 1–55, [CSA], [CROSSREF]
- Watnasirichaikul S. S., Davies N. M., Rades T., Tucker I. G. Preparation of biodegradable insulin nanocapsules from biocompatible microemulsions. Pharm. Res. 2002; 17: 684–689, [CSA], [CROSSREF]